153 related articles for article (PubMed ID: 6834691)
1. Histological renal osteodystrophy, and 25 hydroxycholecalciferol and aluminum levels in patients on continuous ambulatory peritoneal dialysis.
Gokal R; Ramos JM; Ellis HA; Parkinson I; Sweetman V; Dewar J; Ward MK; Kerr DN
Kidney Int; 1983 Jan; 23(1):15-21. PubMed ID: 6834691
[No Abstract] [Full Text] [Related]
2. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
Fournier A; Oprisiu R; Hottelart C; Yverneau PH; Ghazali A; Atik A; Hedri H; Said S; Sechet A; Rasolombololona M; Abighanem O; Sarraj A; El Esper N; Moriniere P; Boudailliez B; Westeel PF; Achard JM; Pruna A
Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
[TBL] [Abstract][Full Text] [Related]
3. Effects of calcifediol treatment on the progression of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
Buccianti G; Bianchi ML; Valenti G; Lorenz M; Cresseri D
Nephron; 1990; 56(4):353-6. PubMed ID: 2079992
[TBL] [Abstract][Full Text] [Related]
4. Controlled study of renal osteodystrophy in patients undergoing dialysis. Improved response to continuous ambulatory peritoneal dialysis compared with hemodialysis.
Shusterman NH; Wasserstein AG; Morrison G; Audet P; Fallon MD; Kaplan F
Am J Med; 1987 Jun; 82(6):1148-56. PubMed ID: 3605132
[TBL] [Abstract][Full Text] [Related]
5. Renal osteodystrophy and metastatic calcification in long-term continuous ambulatory peritoneal dialysis.
Cassidy MJ; Owen JP; Ellis HA; Dewar J; Robinson CJ; Wilkinson R; Ward MK; Kerr DN
Q J Med; 1985 Jan; 54(213):29-48. PubMed ID: 3975345
[TBL] [Abstract][Full Text] [Related]
6. Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis.
Hewitt IK; Stefanidis C; Reilly BJ; Kooh SW; Balfe JW
J Pediatr; 1983 Nov; 103(5):729-34. PubMed ID: 6631599
[TBL] [Abstract][Full Text] [Related]
7. Renal osteodystrophy in children on CAPD: a prospective trial of 1-alpha-hydroxycholecalciferol therapy.
Watson AR; Kooh SW; Tam CS; Reilly BJ; Balfe JW; Vieth R
Child Nephrol Urol; 1988-1989; 9(4):220-7. PubMed ID: 3255485
[TBL] [Abstract][Full Text] [Related]
8. Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis.
Paunier L; Salusky IB; Slatopolsky E; Kangarloo H; Kopple JD; Horst RL; Coburn JW; Fine RN
Pediatr Res; 1984 Aug; 18(8):742-7. PubMed ID: 6472946
[TBL] [Abstract][Full Text] [Related]
9. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
Buccianti G; Bianchi ML; Valenti G
Clin Nephrol; 1984 Dec; 22(6):279-83. PubMed ID: 6525771
[TBL] [Abstract][Full Text] [Related]
10. Value of the new bone classification system for pediatric patients with chronic kidney disease.
Jorgetti V; Drüeke TB
Clin J Am Soc Nephrol; 2010 Oct; 5(10):1730-1. PubMed ID: 20876672
[No Abstract] [Full Text] [Related]
11. Value of the new bone classification system in pediatric renal osteodystrophy.
Bakkaloglu SA; Wesseling-Perry K; Pereira RC; Gales B; Wang HJ; Elashoff RM; Salusky IB
Clin J Am Soc Nephrol; 2010 Oct; 5(10):1860-6. PubMed ID: 20634327
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of ionized calcium and 1,25-dihydroxycholecalciferol loss from peritoneal fluid during peritonitis in patients treated with continuous ambulatory peritoneal dialysis.
Lin CY; Huang TP
Nephron; 1991; 59(1):90-5. PubMed ID: 1944754
[TBL] [Abstract][Full Text] [Related]
13. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG
Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
[TBL] [Abstract][Full Text] [Related]
14. Marked improvement in parameters of renal osteodystrophy with the use of intraperitoneal calcitriol.
Arora N; Sandroni S; Moles K
Adv Perit Dial; 1992; 8():62-4. PubMed ID: 1361854
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.
Fournier A; Bordier P; Gueris J; Sebert JL; Marie P; Ferrière C; Bedrossian J; DeLuca HF
Kidney Int; 1979 Feb; 15(2):196-204. PubMed ID: 513484
[No Abstract] [Full Text] [Related]
16. Efficacy of calcium carbonate and low-dose vitamin D/1,25(OH)2D3 in reducing the risk of developing renal osteodystrophy in children on continuous ambulatory peritoneal dialysis.
Jüppner H; Hoyer PF; Latta K; Winkler L; Offner G; Brodehl J
Pediatr Nephrol; 1990 Nov; 4(6):614-7. PubMed ID: 2088463
[TBL] [Abstract][Full Text] [Related]
17. [Subtotal parathyroidectomy in the treatment of renal osteodystrophy in 8 patients under chronic hemodialysis].
Lillo M
Rev Med Chil; 1984 Jun; 112(6):564-9. PubMed ID: 6515169
[No Abstract] [Full Text] [Related]
18. Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis.
Malluche HH; Faugere MC; Fanti P; Price PA
Kidney Int; 1984 Dec; 26(6):869-74. PubMed ID: 6335905
[TBL] [Abstract][Full Text] [Related]
19. Reversal of aluminum-related bone disease after substituting calcium carbonate for aluminum hydroxide.
Hercz G; Andress DL; Nebeker HG; Shinaberger JH; Sherrard DJ; Coburn JW
Am J Kidney Dis; 1988 Jan; 11(1):70-5. PubMed ID: 3337101
[TBL] [Abstract][Full Text] [Related]
20. Renal osteodystrophy in CAPD patients.
Zucchelli P; Catizone L; Casanova S; Fusaroli M; Fabbri L; Ferrari G
Miner Electrolyte Metab; 1984; 10(5):326-32. PubMed ID: 6493161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
